Shandong Boan Biotechnology Co., Ltd. (6955.HK)

HKSE - HKSE Delayed Price. Currency in HKD

7.900

+0.280

(+3.67%)

At close: 04:08PM HKT

Loading interactive chart...

PR Newswire
Boan Biotech Announces 2024 Half Year Results: Revenue Grows by 39%, Net Profit Increases by RMB 180 Million
Boan Biotech (6955.HK) today announced its 2024 half-year results and latest developments.
PR Newswire
Boan Biotech's Two Innovative Drugs Targeting Claudin 18.2 Granted ODD by FDA
Boan Biotech today announced that two of its Claudin18.2-targeted investigational drugs have been granted the Orphan Drug Designation (ODD) for the treatment of pancreatic cancer by the U.S. Food and Drug Administration (FDA): one is BA1105, an innovative antibody; and the other is BA1301, an innovative Antibody-Drug Conjugate (ADC).